Lv51
841 积分 2021-12-07 加入
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
2小时前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
5小时前
已完结
Understanding the impact of psychosocial working conditions on workers’ health: we have come a long way, but are we there yet?
5小时前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
3天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
6天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
6天前
已完结
Recombinant human thrombopoietin reduces the risk of acute graft-versus-host-disease and its mechanism
9天前
已完结
Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review
10天前
已完结
Herombopag Versus rhTPO in Stem Cell Transplantation: A Comparative Study of Efficacy, Safety, and Cost-Effectiveness
10天前
已完结
Evaluation of the Real-World Efficacy of Hetrombopag for the Treatment of Thrombocytopenia Postallogeneic Hematopoietic Stem Cell Transplantation
10天前
已完结
皖公网安备34019202002308
